Pro-Pharmaceuticals Retains Camargo Pharmaceutical to Provide Strategic Regulatory Support for 505(b)(2) Submissions

Pro-Pharmaceuticals, a company “Advancing Drugs Through Glycoscience,” announced it has retained Camargo Pharmaceutical Services, LLC to provide strategic regulatory support for the Company’s 505(b)(2) submissions with the U.S. Food and Drug Administration (FDA).
Pro-Pharmaceuticals